Accelacare of Wilmington

Clinical research site in Wilmington, North Carolina · 1090 MEDICAL CENTER DR, WILMINGTON, NC 28401-7353 · (910) 763-5259

As of July 2026, 1 paid clinical trial is recruiting at Accelacare of Wilmington in Wilmington, North Carolina. Active studies at this site cover conditions such as Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction and Obesity. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Accelacare of Wilmington (1)

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

for Heart Failure With Preserved Ejection Fraction

110 locations incl. Birmingham

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07037459·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

More research sites in Wilmington

Novant Health New Hanover Regional Medical Center (11 trials)
PPD (4 trials)
Wilmington Health (4 trials)
Accellacare - Wilmington (3 trials)
Atlantic Brain and Spine (3 trials)
New Hanover Regional Medical Center (3 trials)
Wilmington Health, PLLC (3 trials)
Accellacare Wilmington (3 trials)
Accellacare (2 trials)
Accellacare Research of Wilmington (2 trials)

Explore more

Paid clinical trials in Wilmington, NC · North Carolina clinical trials